drugset / Trial / NCT02566733

Minto Model in Effect Site Mode for Target-Controlled Infusion of Remifentanil During Cardiopulmonary Bypass

NCT02566733

Phase 4 Completed 56 enrolled Seoul National University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Target controlled infusion with remifentanil is widely used during cardiac surgery, wich is performed using the Minto model. It was derived from patients undergoing general surgery. However, pharmacokinetics of remifentanil can be changed during cardiopulmonary bypass. The investigators tested whether Minto model for target controlled infusion produces constant plasma remifentanil concentration during the cardiac surgery.

Timeline

Start
2015-10
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule

Indications

No indication recorded.